Pursuant to Chapter 9 of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of AIM wishes to announce that Advance Medipharm Solutions Sdn Bhd [Registration No. 202201033212 (1478909-D)], a wholly-owned subsidiary of the Company, had on 6 October 2022, entered into a Franchise Agreement with Mediconstant Holding Sdn Bhd [Registration No. 200201018975 (586638-X)] ("the Franchisor") for the purpose of obtaining the rights and franchise to operate the business system of the Franchisor in the retailing business of pharmaceutical products and services under the name of “CONSTANT PHARMACY”.

Please refer to the attachment for the details of the Franchise Agreement.

This announcement is dated 6 October 2022.